Hasan, K. M., Elmeshhadany, A. Y., & Shabila, N. P. (2022). Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis. Sultan Qaboos University Medical Journal, 22(3), 393–399. https://doi.org/10.18295/squmj.8.2021.110